41 related articles for article (PubMed ID: 32679000)
1. Saponins as Natural Adjuvant for Antisense Morpholino Oligonucleotides Delivery In Vitro and in mdx Mice.
Wang M; Wu B; Shah SN; Lu P; Lu Q
Mol Ther Nucleic Acids; 2018 Jun; 11():192-202. PubMed ID: 29858054
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of gene expression in Escherichia coli by antisense phosphorodiamidate morpholino oligomers.
Geller BL; Deere JD; Stein DA; Kroeker AD; Moulton HM; Iversen PL
Antimicrob Agents Chemother; 2003 Oct; 47(10):3233-9. PubMed ID: 14506035
[TBL] [Abstract][Full Text] [Related]
3. Using morpholinos for gene knockdown in Giardia intestinalis.
Carpenter ML; Cande WZ
Eukaryot Cell; 2009 Jun; 8(6):916-9. PubMed ID: 19377039
[TBL] [Abstract][Full Text] [Related]
4. Structural Fingerprinting of Antisense Oligonucleotide Therapeutics by Solution NMR Spectroscopy.
Becette OB; Marino JP; Brinson RG
Pharm Res; 2023 Jun; 40(6):1373-1382. PubMed ID: 36195820
[TBL] [Abstract][Full Text] [Related]
5. Dystrophin involvement in peripheral circadian SRF signalling.
Betts CA; Jagannath A; van Westering TL; Bowerman M; Banerjee S; Meng J; Falzarano MS; Cravo L; McClorey G; Meijboom KE; Bhomra A; Lim WF; Rinaldi C; Counsell JR; Chwalenia K; O'Donovan E; Saleh AF; Gait MJ; Morgan JE; Ferlini A; Foster RG; Wood MJ
Life Sci Alliance; 2021 Oct; 4(10):. PubMed ID: 34389686
[TBL] [Abstract][Full Text] [Related]
6. Targeted chitosan nanobubbles as a strategy to down-regulate microRNA-17 into B-cell lymphoma models.
Capolla S; Argenziano M; Bozzer S; D'Agaro T; Bittolo T; De Leo L; Not T; Busato D; Dal Bo M; Toffoli G; Cavalli R; Gattei V; Bomben R; Macor P
Front Immunol; 2023; 14():1200310. PubMed ID: 37359561
[TBL] [Abstract][Full Text] [Related]
7. Nanomedicine for Treating Muscle Dystrophies: Opportunities, Challenges, and Future Perspectives.
Ahmed Z; Qaisar R
Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233338
[TBL] [Abstract][Full Text] [Related]
8. The Proteoglycan Glypican-1 as a Possible Candidate for Innovative Targeted Therapeutic Strategies for Pancreatic Ductal Adenocarcinoma.
Busato D; Mossenta M; Dal Bo M; Macor P; Toffoli G
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142190
[TBL] [Abstract][Full Text] [Related]
9. Exploring chitosan-shelled nanobubbles to improve HER2 + immunotherapy via dendritic cell targeting.
Argenziano M; Occhipinti S; Scomparin A; Angelini C; Novelli F; Soster M; Giovarelli M; Cavalli R
Drug Deliv Transl Res; 2022 Aug; 12(8):2007-2018. PubMed ID: 35672651
[TBL] [Abstract][Full Text] [Related]
10. Antimicrobial oxygen-loaded nanobubbles as promising tools to promote wound healing in hypoxic human keratinocytes.
Banche G; Allizond V; Mandras N; Finesso N; Luganini A; Genova T; Argenziano M; Magnetto C; Gulino GR; Roana J; Tullio V; Giribaldi G; Cavalli R; Spagnolo R; Troia A; Cuffini AM; Prato M
Toxicol Rep; 2022; 9():154-162. PubMed ID: 35145879
[TBL] [Abstract][Full Text] [Related]
11. Nanomedicine, a valuable tool for skeletal muscle disorders: Challenges, promises, and limitations.
Colapicchioni V; Millozzi F; Parolini O; Palacios D
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2022 May; 14(3):e1777. PubMed ID: 35092179
[TBL] [Abstract][Full Text] [Related]
12. Carbosilane Dendrimers Loaded with siRNA Targeting Nrf2 as a Tool to Overcome Cisplatin Chemoresistance in Bladder Cancer Cells.
Ambrosio L; Argenziano M; Cucci MA; Grattarola M; de Graaf IAM; Dianzani C; Barrera G; Sánchez Nieves J; Gomez R; Cavalli R; Pizzimenti S
Antioxidants (Basel); 2020 Oct; 9(10):. PubMed ID: 33066634
[TBL] [Abstract][Full Text] [Related]
13. Morpholino-mediated Knockdown of DUX4 Toward Facioscapulohumeral Muscular Dystrophy Therapeutics.
Chen JC; King OD; Zhang Y; Clayton NP; Spencer C; Wentworth BM; Emerson CP; Wagner KR
Mol Ther; 2016 Aug; 24(8):1405-11. PubMed ID: 27378237
[TBL] [Abstract][Full Text] [Related]
14. Exon Skipping Using Antisense Oligonucleotides for Laminin-Alpha2-Deficient Muscular Dystrophy.
Hara Y; Mizobe Y; Miyatake S; Takizawa H; Nagata T; Yokota T; Takeda S; Aoki Y
Methods Mol Biol; 2018; 1828():553-564. PubMed ID: 30171567
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of 5'-Thiol Functionalized Morpholino Oligo-Nucleotide and Subsequent Conjugation with IGT to Improve Delivery and Antisense Efficacy
Ghosh U; Gupta S; Sinha S
Bioconjug Chem; 2023 Jan; 34(1):174-180. PubMed ID: 36538654
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of Backbone-Modified Morpholino Oligonucleotides Using Phosphoramidite Chemistry.
Paul S; Caruthers MH
Molecules; 2023 Jul; 28(14):. PubMed ID: 37513252
[TBL] [Abstract][Full Text] [Related]
17. Antisense Phosphorodiamidate Morpholino Oligomers as Novel Antiviral Compounds.
Nan Y; Zhang YJ
Front Microbiol; 2018; 9():750. PubMed ID: 29731743
[TBL] [Abstract][Full Text] [Related]
18. Chitosan-Shelled Nanobubbles Irreversibly Encapsulate Morpholino Conjugate Antisense Oligonucleotides and Are Ineffective for Phosphorodiamidate Morpholino-Mediated Gene Silencing of
Falzarano MS; Argenziano M; Marsollier AC; Mariot V; Rossi D; Selvatici R; Dumonceaux J; Cavalli R; Ferlini A
Nucleic Acid Ther; 2021 Jun; 31(3):201-207. PubMed ID: 32679000
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
